$CLX

Clorox vs. Colgate: One Pays Nearly 6%, but Is It a Dividend Trap?

Clorox (CLX) offers a higher dividend yield (5.89%) than Colgate-Palmolive (CL) (2.27%), but its financial health raises concerns. Clorox's stock fell 22.44% in the past year, increasing its yield, while Colgate's rose 23.55%. Clorox's dividend payout ratio is thin, and its gross margin and cash flow have declined. Colgate shows stronger financials, with rising margins and free cash flow, and a longer dividend growth track record. Analysts prefer Colgate for its stability and growth prospects.

Original reporting
Published Oct 20, 2026, 12:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 12:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Clorox vs. Colgate: One Pays Nearly 6%, but Is It a Dividend Trap? — source image
Decision brief

The 30-second read

$CLXBearishLow
01

Why it matters

Provides a qualitative assessment of each company's dividend sustainability and growth prospects, suggesting possible investor reallocation.

02

Market read

The piece offers a comparative view for income investors, potentially influencing allocation within the consumer‑staples sector.

03

What to watch

Potential upside from the GOJO/Purell integration synergies and any future share buybacks are not quantified.

Relevance 4/10Novelty 2/10Timing: none

Background

The article compares two dividend‑paying consumer‑staples companies, focusing on yield, cash flow, margin trends, and dividend history to guide retirement‑oriented investors.

Company-level read

Ticker impact

$CLXBearishMedium confidence
Context

Clorox is highlighted for its high 5.89% forward yield but flagged for margin pressure, debt load and a potentially unsustainable payout.

Expected impact

likely pressure as investors reassess dividend risk

Evidence & confidence

The article points to falling margins, rising debt and a thin earnings buffer, suggesting the stock may be downgraded or see selling pressure.

$CLBullishMedium confidence
Context

Colgate‑Palmolive is presented as a stronger retirement stock with lower yield but growing margins, strong cash flow and a 63‑year dividend streak.

Expected impact

potential support as income investors favor the stock

Evidence & confidence

The article emphasizes solid cash flow, dividend growth and lower volatility, which could buoy the share price.

Market effects

Highlights dividend‑yield considerations in consumer staples, potentially influencing sector rotation toward lower‑risk dividend aristocrats.

U.S. consumer‑staples investors may shift allocations between CLX and CL based on dividend sustainability.

Limited; the discussion is confined to two U.S. listed consumer‑staples firms.

Counterpoint

Clorox's high yield could be a value trap, but if margin recovery materializes, the stock may rebound sharply.

Key entities

  • Clorox Company

    U.S. consumer‑staples firm with a 5.89% forward dividend yield.

  • Colgate‑Palmolive Company

    U.S. consumer‑staples firm with a 2.27% dividend yield and a 63‑year dividend‑increase streak.

Related articles

$KMBMed

Kimberly-Clark vs. Clorox: Which Dividend Stock Pays You More in 10 Years?

Clorox (CLX) and Kimberly-Clark (KMB) are compared for their dividend payouts. CLX offers a 6.2% yield, but its dividends exceeded free cash flow in fiscal 2026. KMB yields 5.4%, with dividends covered by free cash flow. CLX's net debt increased post-acquisition, while KMB faces China-related sales challenges. Both companies' dividend policies and financial health are analyzed.

$KHCMed

Better High-Yield Dividend Stock: Kraft Heinz vs. Clorox

Kraft Heinz (KHC) and Clorox (CLX) are compared as high-yield dividend stocks. KHC yields 7.2% with a 50% payout ratio, while CLX yields 6.1% with a 149% payout ratio. KHC guided 2026 adjusted operating income down 16-18%, and CLX's free cash flow fell to $405M in fiscal 2026. CLX's debt increased to 4.3x EBITDA post-GOJO deal.